1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. AUROBINDO PHARMA LTD.
Aurobindo Pharma Ltd. Ask MarketMind AI v1.5
NSE: AUROPHARMA | BSE: 524804
Turnaround Potential
In 3 Starfolio Baskets
Download real time
1296.50 -15.40 (-1.17%)
New 52W High in past week
1.7M
NSE+BSE Volume

NSE 13 Mar, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Observation
Aurobindo Pharma's arm APL Healthcare, receives Form-483 with five observations from the US FDA See details

Aurobindo Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents